The Ministry of Health, Labour and Welfare (MHLW) in Japan oversees drug regulation by ensuring the safety, efficacy, and quality of pharmaceuticals. The PMDA, under the MHLW, evaluates new drugs, grants approvals, monitors adverse effects, and enforces compliance with standards, thereby safeguarding public health and promoting the well-being of the population.